1. Fraietta, Joseph A, Nobles, Christopher L, Sammons, Morgan A, June, Carl H, Melenhorst, J Joseph. 2018. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. In Nature, 558, 307-312. doi:10.1038/s41586-018-0178-z. https://pubmed.ncbi.nlm.nih.gov/29849141/
2. Eyquem, Justin, Mansilla-Soto, Jorge, Giavridis, Theodoros, Gönen, Mithat, Sadelain, Michel. 2017. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. In Nature, 543, 113-117. doi:10.1038/nature21405. https://pubmed.ncbi.nlm.nih.gov/28225754/
3. Trevisan, Glauce L, Rassi, Diane M, Baião, Ana M T, Donadi, Eduardo A, Passos, Geraldo A S. 2006. Using cDNA microarrays to identify human CD19(+) B cell gene products (ESTs) originated from systemic lupus erythematosus susceptibility loci. In Autoimmunity reviews, 5, 319-23. doi:. https://pubmed.ncbi.nlm.nih.gov/16782556/
4. Kehrl, J H, Riva, A, Wilson, G L, Thévenin, C. . Molecular mechanisms regulating CD19, CD20 and CD22 gene expression. In Immunology today, 15, 432-6. doi:. https://pubmed.ncbi.nlm.nih.gov/7524520/
5. Ang, Zhiwei, Paruzzo, Luca, Hayer, Katharina E, Schuster, Stephen J, Thomas-Tikhonenko, Andrei. . Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies. In Blood, 142, 1724-1739. doi:10.1182/blood.2023020400. https://pubmed.ncbi.nlm.nih.gov/37683180/
6. Guercio, Marika, Manni, Simona, Boffa, Iolanda, Quintarelli, Concetta, Locatelli, Franco. 2021. Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies. In Frontiers in immunology, 12, 755639. doi:10.3389/fimmu.2021.755639. https://pubmed.ncbi.nlm.nih.gov/34737753/
7. Kozmik, Z, Wang, S, Dörfler, P, Adams, B, Busslinger, M. . The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. In Molecular and cellular biology, 12, 2662-72. doi:. https://pubmed.ncbi.nlm.nih.gov/1375324/
智鼠故事 
